Compounds derived from oxazolidin - 1.3 - 2 - one and 2 - oxo - 1.3 - imidazoline, inhibitor of Calcium activated Potassium Channel (kca3.1)； Pharmaceutical composition； Treatment method； and use for the Treatment or prophylaxis of polycystic kidney disease, Asthma, Brain Edema and INTEST disease No inflammatory, among others.

• 收藏
• 分享

专利权人:

F. HOFFMANN-LA ROCHE AG

发明人:

GREEN, LUKE,WANG, HAIYAN

申请号：

CL2015000906

公开号：

CL2015000906A1

申请日:

2015.04.10

申请国别(地区):

CL

年份:

2015

代理人:

摘要：

The invention provides compounds having the general formula I wherein n, R1, R2a, R2b, R3a and R3b are as herein defined, composition comprising the compounds and methods of using the compounds.<；p>；COMPUESTOS DERIVADOS DE 2-OXO- OXAZOLIDIN CON ACTIVIDAD BLOQUEADORA DEL KCA3.1 Ú；TILES EN EL TRATAMIENTO DE LA ENFERMEDAD RENAL POLIQUISTICA, ASMA, EDEMA CEREBRAL, RECHAZO A TRASPLANTE, ATEROSCLEROSIS, FIBROSIS RENAL, CÁ；NCER, ENTRE OTRAS.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/